Contact
Please use this form to send email to PR contact of this press release:
Alterity Therapeutics Reports Positive Interim Data from ATH434-202 Phase 2 Clinical Trial in Multiple System Atrophy
TO:
Please use this form to send email to PR contact of this press release:
Alterity Therapeutics Reports Positive Interim Data from ATH434-202 Phase 2 Clinical Trial in Multiple System Atrophy
TO: